Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 401–500 of 870
Ismail, C. A. N., Suppıan, R., Aziz, C. B. A., & Long, I. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.102003 · Cited by 15
Maiga, Y. M., Diallo, S., Konipo, F. D. N., Sangho, O., Sangaré, M., Diallo, S. H., Saliou, M., Péréon, Y., Giumelli, B., Coulibaly, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241387 · Cited by 20
“We found a female predominance and a higher frequency of type 2 diabetes, which is in line with what has been reported in the literature [35, 38].”
BackgroundResultJoharchi, K., Memari, M., Azargashb, E., & Saadat, N. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00427-w · Cited by 16
Rodríguez-Sánchez, B., Peña-Longobardo, L. M., & Sinclair, A. J. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01134-2 · Cited by 17
Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review
Galosi, E., Hu, X., Michael, N., Nyengaard, J. R., Truini, A., & Karlsson, P. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01767-x · Cited by 16
Impact of Exercise Training in Patients with Diabetic Peripheral Neuropathy: An Umbrella Review
Gracia‐Sánchez, A., López‐Pineda, A., Nouni-García, R., Zúnica‐García, S., Chicharro‐Luna, E., & Gil-Guillén, V. F. (2025) · Sports Medicine - Open · doi:10.1186/s40798-025-00863-4 · Cited by 28
“Epidemiological studies have reported that DPN prevalence ranges from 6 to 51%, depending on the population studied [7–10].”
Diabetic peripheral neuropathy: age-stratified glycemic control
Wang, C.-S., Pai, Y., Lin, C., Lee, I., Chen, H.-H., & Chang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1377923 · Cited by 24
“However, in clinical practice, T2DM is the most prevalent form of DM, and more than 90% of DPN cases can be attributed to T2DM (19).”
BackgroundBober, A., Piotrowska, A., Pawlik, K., Ciapała, K., Maciuszek, M., Makuch, W., & Mika, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137410 · Cited by 17
“Painful symptoms are present in 26% of patients without neuropathy and in 60% of patients with severe neuropathy [4].”
BackgroundInfluentialCastañeda‐Corral, G., Velázquez-Salazar, N. B., Martínez-Martínez, A., Taboada-Serrano, J. N., Núñez-Aragón, P. N., González-Palomares, L., Acosta‐González, R. I., Petricevich, V. L., Acevedo‐Fernández, J. J., Montes, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.628438 · Cited by 15
“Although a large number of patients with DPN may be asymptomatic, approximately a quarter of people with T2DM suffer from painful DPN as a result of damage to or dysfunction of the sensory nerve fibers, along with a loss of the nerve fiber axons within the skin (Abbott et al., 2011).”
BackgroundAnalgesic purchases among older adults – a population-based study
Marttinen, M. K., Kautiainen, H., Haanpää, M. L., Pohjankoski, H., Hintikka, J. J., & Kauppi, M. J. (2021) · BMC Public Health · doi:10.1186/s12889-021-10272-3 · Cited by 18
Adler, M., & Taxer, B. (2021) · Der Schmerz · doi:10.1007/s00482-021-00576-z · Cited by 16
Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN)
Sharma, S., & Rayman, G. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165505 · Cited by 20
“The major drawback of such a device is its manual observer-dependent operability and its limited vibration intensity (35, 36).”
BackgroundHe, W., Zhang, B., Zhao, W., He, J., Zhang, L., Xiong, Q., Wang, J., & Wang, H. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00680 · Cited by 17
Kaymaz, S., Alkan, H., Karasu, U., & Çobankara, V. (2020) · Diabetology International · doi:10.1007/s13340-020-00427-9 · Cited by 18
Pragmatic Opioid Use in Painful Diabetic Neuropathy
Balhara, Y. P. S., Singh, S., & Kalra, S. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.1.21 · Cited by 15
“South Asians are particularly prone to this complication which leads to decreased quality of life and increased healthcare costs.(4) The symptomatic management of PDN with a single treatment approach remains a challenge.”
BackgroundTrained immunity: novel perspectives in diabetes and associated complications
Liu, Y., Lei, Y., Dai, Z., Luo, C., Gong, Q., Li, Y., Xu, Y., & Huang, W. G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1613602 · Cited by 17
“The clinical impact of diabetes extends beyond hyperglycemia itself, manifesting as secondary systemic damage affecting cardiovascular (2), neurological (3) and renal systems (4).”
Rohmann, R., Kuhn, E. M., Scherbaum, R., Hilker, L., Kools, S., Scholz, L., Müller, K., Huckemann, S., Schneider‐Gold, C., Gold, R., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11070879 · Cited by 13
“7%) patients in our study with at least mild neuropathic symptoms (NSS > 2) remains high, compared to a diabetic population where only 48% have an NSS > 2 points [38].”
Zhu, B. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022012 · Cited by 17
“Diabetic neuropathy Over 50% of DM patients eventually develop neuropathy [355].”
BackgroundPainful Diabetic Peripheral Neuropathy – A Survey of Patient Experiences
Abd-Elsayed, A. A., MARCONDES, L. P., Loris, Z. B., & Reilly, D. (2023) · Journal of Pain Research · doi:10.2147/jpr.s409876 · Cited by 17
A Review of Diabetic Peripheral Neuropathy Management given Recent Guidelines Updates.
Hamed, E. S., & Monem, M. A. (2018) · Archives of General Internal Medicine · doi:10.4066/2591-7951.1000060 · Cited by 14
AlSufyani, M. H., Alzahrani, A. M., Allah, A. A., Abdullah, R. I., Alzhrani, S. H., & Alsaab, A. A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_488_20 · Cited by 15
The Influence of Dietary Supplementations on Neuropathic Pain
D’Egidio, F., Lombardozzi, G., Kacem, H., Mastroiacovo, G., Alfonsetti, M., & Cimini, A. (2022) · Life · doi:10.3390/life12081125 · Cited by 19
Lin, I., Wang, Y., Lin, C., Chang, Y., Lee, S., & Wang, I. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12746 · Cited by 14
“The prevalence rate of diabetic neuropathic pain is approximately 10–20% among the diabetic population, and approximately 40–60% in patients with documented neuropathy (Galer et al. 2000; Daousi et al. 2004; Abbott et al. 2011).”
BackgroundAnderson, S. G., Malipatil, N. S., Roberts, H., Dunn, G., & Heald, A. H. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.08.004 · Cited by 13
“[5] C.”
BackgroundCoppini, D. V. (2016) · Diabetic Medicine · doi:10.1111/dme.13089 · Cited by 13
Carrer, P., Trevisan, C., Curreri, C., Giantin, V., Maggi, S., Crepaldi, G., Manzato, E., & Sergi, G. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2017.08.480 · Cited by 14
Fan, J. W., Jeffery, M. M., Hooten, W. M., Shah, N. D., & McCoy, R. G. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.35632 · Cited by 16
Ehmke, T., Leckelt, J., Reichard, M., Weiß, H., Hovakimyan, M., Heisterkamp, A., Stachs, O., & Baltrusch, S. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.11.024 · Cited by 13
Pek, S. L. T., Sum, C. F., Yeoh, L. Y., Lee, S. B. M., Tang, W. E., Lim, S. C., & Subramaniam, T. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.016 · Cited by 14
Shiva, F., Nouri-Majd, S., Asadi, S., Rasaei, N., Hasanzadeh, M., Qorbani, M., Mirzaei, K., Aminianfar, A., & Asadi, S. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.06.012 · Cited by 12
Zhang, Y., Zhang, Q., Bai, Y., Zheng, H., Ji, L., Zhu, X., Sun, W., Liu, X., Zhang, S., Li, Y., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108416 · Cited by 13
Pop‐Busui, R., Patel, A., Sang, C. N.-M., Banks, P. L., Pierce, P. F., Sun, F., Granowitz, C. B., & Gopinathan, S. (2024) · Diabetes Care · doi:10.2337/dc24-0188 · Cited by 15
Altered surface-based brain morphometry in type 1 diabetes and neuropathic pain
Hostrup, S. N., Croosu, S. S., Røikjer, J., Mørch, C. D., Ejskjær, N., Hansen, T. M., & Frøkjær, J. B. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.033 · Cited by 13
Prevalence of Diabetes and Diabetic Neuropathy in Qena Governorate: Population-Based Survey
Khedr, E. M., Fawi, G., Abbas, M. A. A., Elfetoh, N. A., Al-Attar, G. S. T., Zaki, A. F., & Gamea, A. (2016) · Neuroepidemiology · doi:10.1159/000444056 · Cited by 12
Rebouças, E. D. L., da Silva, A. W., Rodrigues, M. C., Ferreira, M. K. A., Mendes, F. R. D. S., Marinho, M. M., Marinho, E. M., Pereira, L. R., de Araújo, J. I. F., da Silva, J. Y. G., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1981449 · Cited by 13
“Among people with DM, neuropathic pain has received attention because of its prevalence rate of 13%–26% (Abbott et al., 2011; Ziegler & Fonseca, 2015).”
BackgroundChan, K. W., Smeijer, J. D., Schechter, M., Jongs, N., Vart, P., Kohan, D. E., Gansevoort, R. T., Liew, A., Tang, S. C. W., Wanner, C., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.08.014 · Cited by 12
Relationship between diabetic neuropathy and occurrence of depression among diabetic patients
Dziemidok, P., Dąbrowski, M., & Makara‐Studzińska, M. (2015) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/42352 · Cited by 14
“On the basis of analyses performed in the United Kingdom it was found that 1/3 of diabetic patients complained of the symptoms of neuropathic pain [13].”
BackgroundKoetsier, E., van Kuijk, S. M. J., Melli, G., Dukanac, J., Barbero, M., Zundert, J. H. M. V., Joosten, E. A. J., & Maino, P. (2020) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13336 · Cited by 13
Karalis, D. T., Karalis, T., Karalis, S., Kleisiari, A. S., Malakoudi, F., & Maimari, K. E. V. (2021) · Cureus · doi:10.7759/cureus.12773 · Cited by 16
“It is an aesthetic-motor polyneuropathy with progressive severity of symptoms that results in functional decline and reduced quality of life [14-15].”
BackgroundGad, H., Al‐Jarrah, B., Saraswathi, S., Mohamed, S., Kalteniece, A., Petropoulos, I. N., Khan, A., Ponirakis, G., Singh, P., Khodor, S. A., et al. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-319057 · Cited by 13
Self-citationAltered Functional Connectivity of Insular Subregions in Type 2 Diabetes Mellitus
Zhang, D., Wang, M., Gao, J., Huang, Y., Qi, F., Lei, Y., Ai, K., Yan, X., Cheng, M., Su, Y., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.676624 · Cited by 14
“Approximately 60% of patients with T2DM have different degrees of peripheral neuropathy (Abbott et al., 2011).”
BackgroundCrasto, W., Altaf, Q., Selvaraj, D. R., Jack, B., Patel, V., Nawaz, S., Murthy, N., Sukumar, N., Saravanan, P., & Tahrani, A. A. (2021) · Diabetic Medicine · doi:10.1111/dme.14710 · Cited by 12
Madi, M., Hamzeh, H., Abujaber, S., & Altubasi, I. M. (2021) · Disability and Rehabilitation · doi:10.1080/09638288.2021.2006322 · Cited by 12
Tan, E. D. D., Davis, W. A., & Davis, T. M. E. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12267 · Cited by 11
Gölaç, H., Atalık, G., Kemaloğlu, Y. K., & YILMAZ, M. (2022) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5372 · Cited by 13
Effect of Diabetes Mellitus Type 2 on Voice: A Systematic Review and Meta-Analysis
Hamdan, A., Daou, C. A. Z., Hosri, J., Feghali, P. A. R., Jabbour, C., Alam, E. S., & Mourad, M. (2023) · Folia Phoniatrica et Logopaedica · doi:10.1159/000534271 · Cited by 11
Beulens, J. W. J., Reichelt, F., Remmelzwaal, S., Rutters, F., Strooij, B. T., Harms, P., de Vries, R., Blom, M. T., Stronks, K., & Muilwijk, M. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004345 · Cited by 15
Luk, A. O. Y., Fan, Y., Fan, B., Chow, E. W. K., & Tony, C. K. O. (2025) · Diabetologia · doi:10.1007/s00125-025-06482-8 · Cited by 19
“The reported prevalence of diabetic neuropathy among minority ethnic populations is generally similar to or lower than that among White individuals [110, 113].”
Kaewput, W., Thongprayoon, C., Rangsin, R., Mao, M. A., Satirapoj, B., & Cheungpasitporn, W. (2018) · Hospital Practice · doi:10.1080/21548331.2019.1549916 · Cited by 11
van Laake‐Geelen, C. C. M., Smeets, R., Goossens, M. E. J. B., & Verbunt, J. (2021) · Journal of Rehabilitation Medicine – Clinical Communications · doi:10.2340/20030711-1000046 · Cited by 12
A Study on Peripheral Neuropathy and Its Related Risk Factors Associated With hba1c Levels
Hossain, M., Sarkar, M., Mahbub, I., & Islam, S. (2021) · Journal of Bio-Science · doi:10.3329/jbs.v29i2.54961 · Cited by 14
Mechanisms of exercise for diabetic neuropathic pain
Luo, J., Zhu, H.-Q., Gou, B., & Zheng, Y.-L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.975453 · Cited by 14
“At present, the number of patients with diabetes mellitus is very large, and one-thirds of them present with DNP (Abbott et al., 2011).”
BackgroundAxonal Sensorimotor Polyneuropathies
Li, Y. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000514 · Cited by 16
Zhang, Y., Li, N., Zhao, Y., & Fan, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025722 · Cited by 13
Metabolic health and vascular complications in type 1 diabetes
Bhattarai, S., Godsland, I. F., Misra, S., Johnston, D. G., & Oliver, N. S. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.026 · Cited by 12
Clinical electrophysiology of axonal polyneuropathies
McCorquodale, D. S., & Smith, A. G. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64142-7.00051-5 · Cited by 12
Park, S. Y., & Park, C.-H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189635 · Cited by 12
“DN has a high prevalence among diabetic patients [2,3].”
BackgroundTesfaye, S. H. (2018) · Medicine · doi:10.1016/j.mpmed.2018.11.009 · Cited by 12
Current glycaemic control has no impact on the advancement of diabetic neuropathy.
Dziemidok, P., Szczęśniak, G., Kostrzewa-Zabłocka, E., Paprzycki, P., & Korzon-Burakowska, A. (2012) · PubMed · Cited by 12
An Overview on Diabetic Neuropathy
Singh, U., Sharma, R., & Kumar, R. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998295741240606104106 · Cited by 14
Bober, A., Mika, J., & Piotrowska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011323 · Cited by 14
SLOAN, G. P., DONATIEN, P. D., Privitera, R., SHILLO, P. R., Caunt, S., Selvarajah, D., Anand, P., & Tesfaye, S. H. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1485420 · Cited by 10
Calcutt, N. A. (2013) · Diabetes · doi:10.2337/db13-1158 · Cited by 10
Diabetic Peripheral Neuropathic Pain From the Perspective of Turkish Patients: A Qualitative Study
Metin, Z. G., & Arslan, I. E. (2018) · Journal of Transcultural Nursing · doi:10.1177/1043659617753044 · Cited by 10
The time to develop treatments for diabetic neuropathy
Rendell, M. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1868433 · Cited by 10
Low T3 syndrome is associated with peripheral neuropathy in patients with type 2 diabetes mellitus
He, W., Pang, C., Chen, L., Zeng, Y., Gao, L., Huang, H., Zhang, W., Wang, X., & Deng, B. (2022) · Muscle & Nerve · doi:10.1002/mus.27719 · Cited by 11
“Symptoms were assessed using the Neuropathy Disability Score (NDS) based on ankle reflexes (using a tendon hammer), vibration sensation (using a 128-Hz tuning fork), pinprick sensation (using a Neurotip [Owen Mumford, Inc, Oxfordshire, UK]), and temperature sensation (using warm and cool rods) at the hallux of each si…”
MethodDweib, M., & Sharif, N. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216719 · Cited by 18
“[43].”
Elafros, M. A., Brown, A., Marcus, H., Dawood, T., Bachuwa, G., Banerjee, M., Winch, P., Kvalsund, M. P., Feldman, E. L., Skolarus, L. E., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209390 · Cited by 7
Understanding and treating painful diabetic neuropathy: time for a paradigm shift
Gandhi, R. A., & Selvarajah, D. (2015) · Diabetic Medicine · doi:10.1111/dme.12755 · Cited by 9
Tsai, C.-I., Li, T., Chang, M., Lin, S., Lee, I., Lee, C.-H., Wang, T.-Y., & Su, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/767498 · Cited by 14
Do, J. G., Noh, S. U., Chae, S. W., Yoon, K. J., & Lee, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-67601-6 · Cited by 11
Djouhri, L., Zeidan, A., & El‐Aleem, S. A. A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135277 · Cited by 16
Tıwarı, R., Wal, P., Singh, P., Tiwari, G., & Rai, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200914141558 · Cited by 10
The Last Decade Publications on Diabetic Peripheral Neuropathic Pain: A Bibliometric Analysis
Du, S.-H., Zheng, Y.-L., Zhang, Y., Wang, M., & Wang, X. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.854000 · Cited by 10
“Diabetes mellitus refers to a series of metabolic diseases distinguished by high blood sugar, which is mainly caused by lack of insulin secretion, defective action, or both (Abbott et al., 2011).”
BackgroundVogt, E., Øksnes, M., Suleiman, F., Juma, B. A., Thordarson, H. B., Ommedal, O., & Søfteland, E. W. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.09.001 · Cited by 13
The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy
Stevens, M., Neal, C. R., Crăciun, E. C., Dronca, M., Harper, S. J., & Oltean, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212910 · Cited by 10
Understanding Pain in Order to Treat Patients in Pain
Catley, M. J., Moseley, G. L., & Jones, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-5976-6.00007-3 · Cited by 18
Alkhudhayri, S., Sajini, R., Alharbi, B., Qabbani, J., Alhindi, Y. Z., Fairaq, A., & Yousef, A. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.209 · Cited by 11
Roohi, T. F., Mehdi, S., Aarfi, S., Krishna, K. L., Pathak, S., Suhail, S. M., & Faizan, S. (2023) · Diabetology International · doi:10.1007/s13340-023-00680-8 · Cited by 12
Health-related quality of life and spinal cord stimulation in painful diabetic neuropathy
Taylor, R. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110826 · Cited by 8
Peng, Y., Zhang, A. H., Wei, L., & Welsh, W. J. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00186 · Cited by 10
Wei, W., Fang, J., Yang, B., Cui, C., Wei, J., & Xue, Y. (2024) · The Korean journal of pain · doi:10.3344/kjp.24244 · Cited by 11
Emara, S. M., Fahmy, S., Abdelsalam, M., & Wakeel, L. M. E. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01624-9 · Cited by 11
“Pain is typically coupled with sensory sensations [4], with severe pain more pronounced in females and connected with the severity of DPN [5].”
Correlates of diabetic polyneuropathy of the elderly in Sub-Saharan Africa
Simo, N., Kuate-Tegueu, C., Ngankou, S., Doumbe, J. N., Maiga, Y. M., Cesari, M., Dartigues, J., Kengne, A. P., & Tabué-Teguo, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240602 · Cited by 11
The role of purinergic signaling in acupuncture-mediated relief of neuropathic and inflammatory pain
Huo, M., Zhang, Q., Si, Y., Zhang, Y., Chang, H., Zhou, M., Zhang, D., & Fang, Y. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-09985-y · Cited by 9
“DNP is a highly prevalent and debilitating diabetic complication that affects the quality of life of many diabetic individuals [99].”
Diabetic neuropathy and the sensory apparatus “meissner corpuscle and merkel cells”
Alsunousi, S. I. A., & Marrif, H. I. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00079 · Cited by 10
Biology and Pathophysiology of Painful Diabetic Neuropathy
Mixcoatl-Zecuatl, T., & Calcutt, N. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6299-6_2 · Cited by 9
Neykov, M., Liu, J. S., & Cai, T. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 9
Wang, P. H., Yang, C.-C., Su, W., Wu, P., Cheng, S.-C., & Jou, I. (2017) · Journal of Pain Research · doi:10.2147/jpr.s125693 · Cited by 9
Zhou, X., Zhu, Y., Wang, Z., Lin, Z. Q., Zhu, D., Xie, C., Calcutt, N. A., & Guan, Y. (2022) · Diabetes · doi:10.2337/db21-0960 · Cited by 10
Alam, U., Nelson, A. J., Cuthbertson, D. J., & Malik, R. A. (2018) · Future Neurology · doi:10.2217/fnl-2017-0034 · Cited by 9
Self-citationLong non coding RNAs involved in MAPK pathway mechanism mediates diabetic neuropathic pain
Ren, X., Yang, R., Li, L., Xu, X., & Liang, S. (2020) · Cell Biology International · doi:10.1002/cbin.11457 · Cited by 10
“The environmental risk factors for DNP include increasing age, obesity, persistence of diabetes, and sex gender (Abbott et al., 2011; Van Acker et al., 2009; Raputova et al., 2017; Ziegler et al., 2009).”
BackgroundLi, Y., Toyama, K., Nakatsu, T., et al. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02424-7 · Cited by 8
SLOAN, G. P., Teh, K., Caunt, S., Wilkinson, I. D., Selvarajah, D., & Tesfaye, S. H. (2024) · Diabetes · doi:10.2337/db23-0931 · Cited by 9
Määttä, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Witte, D. R., John, J., Pascal, M. M. V., Ferris, E., Baskozos, G., Ramirez, J. D., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112098 · Cited by 10
He, D., Hao, Z., Zhao, M., Li, M., Hou, N., Yu, Y., Cheng, L. L., & Jia, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03488-z · Cited by 13
“On the other hand, because it is dif fi cult to collect fMRI data from patients, to include more studies, we set a sample size of at least 10 as one of the inclusion criteria for this meta-analysis.”
Nagata, K., Miyahara, J., Nakamoto, H., Kawamura, N., Takeshita, Y., Higashikawa, A., Ono, T., Fukushima, M., Okazaki, R., Hara, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13838-2 · Cited by 9
“At baseline and one year after surgery, all patients were asked to answer a booklet of questionnaires, including the Japanese version of the (1) Numerical Rating Scale (NRS), (2) the Short Form-12 Physical Component Summary (PCS), (3) Mental Component Summary (MCS), (4) Euro quality of life 5-dimmension (EQ-5D)-3L to…”
MethodZhang, J. Y., He, M., Gao, G., & Sun, T. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2358741 · Cited by 9
Moriarty, O., Lang, Y., Idrees, Z., McGuire, B. E., & Finn, D. P. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.027 · Cited by 10
“The incidence of diabetic neuropathy is correlated positively with diabetes duration [1], and the prevalence of painful neuropathic symptoms in diabetic patients has been estimated at ~ 34% [2].”
BackgroundBattecha, K. H. (2017) · Bulletin of Faculty of Physical Therapy · doi:10.4103/1110-6611.209877 · Cited by 10
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
